Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...

Republican SEC Commissioner Mark Uyeda suggests pausing new enforcement actions against firms that have failed to register ...

"We are pleased the SEC has declared effective the registration statement and that the proxy statement has been mailed, marking a significant milestone in our proposed business combination with Roth ...

The SEC failed to adequately plead claims that the Binance.US cryptocurrency exchange violated securities laws by failing to ...

Unity Software (NYSE:U) has filed a registration statement with the SEC for a proposed offering of securities. The ...

Kraken’s attorney, Michael O’Connor, criticized the SEC’s move on Wednesday, calling it an ‘Election Day gambit.’ ...

The crypto industry poured millions of dollars into the presidential and congressional races, but its most salient election ...

Investment firms Capital Group and KKR filed registration statements with the SEC for two public-private fixed income funds.

The Securities and Exchange Commission’s Division of Examinations ... should pay particular attention to the risks posed by conflicts of interest. Dual registration may create an incentive for ...

Pharma Two B and Hepion Pharmaceuticals (HEPA) announced that the U.S. Securities and Exchange Commission has declared effective the ...

has filed a registration statement on Form S-4 with the Securities and Exchange Commission (“SEC”) relating to the previously announced proposed merger ( the “Merger”) with Verde Bioresins, Inc.

Binance files to dismiss the SEC's amended complaint, challenging vague securities rules and highlighting regulatory uncertainty in crypto.